Oscar Health

Oscar Health, Inc. operates as a health insurance company which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Oscar Health reports robust growth and profitability outlook for 2023

Oscar Health's 2022 performance showcased strong growth in membership, improved financial ratios, and a focus on efficiency and profitability in the insurance business.
The company's strengths lie in exceeding targets for capital, stable premiums, and leveraging investment income for competitive advantage.
Challenges include financial transparency and managing risk pool dynamics, while opportunities exist in market expansion, PBM contract benefits, and margin expansion strategies.
Overall, Oscar Health's strategic focus on growth, efficiency, and profitability positions it well for future success in the insurance market.

Oscar Health achieves Q1 profitability, focuses on tech innovation

Oscar Health's Q1 2023 earnings call highlighted strong financial performance, operational efficiency, and a strategic focus on profitability priorities.
While facing challenges such as reshaping strategies and market-specific dynamics, the company is well-positioned to leverage opportunities for growth and innovation.
With a mission-driven approach, a growing member base, and a commitment to enhancing technology, Oscar Health aims to sustain profitability and market competitiveness.

Oscar Health reports strong Q2 earnings, eyes growth opportunities

Oscar Health's Q2 performance reflects positive trends in profitability, membership growth, and strategic planning for future expansion.
While facing challenges in pricing strategies and achieving profitability targets, the company is well-positioned to capitalize on growth opportunities.
With a focus on innovation, customer satisfaction, and market expansion, Oscar Health aims to strengthen its competitive position in the healthcare industry.

Oscar Health excels in Q3, eyes profitability in 2024

Oscar Health's Q3 2023 earnings call highlighted strong performance metrics, a focus on profitability in 2024, and strategic initiatives to drive growth and enhance member satisfaction. While facing challenges in narrowing EBITDA losses, the company remains optimistic about its trajectory and expressed confidence in its strategic direction and employee dedication.

Oscar Health achieves insurance profitability, eyes growth amid market changes

Oscar Health's Q4 2023 Earnings Call highlighted achievements in insurance company profitability and significant improvements in total company adjusted EBITDA.
The company is well-positioned for profitability in 2024, focusing on serving over 1.3 million members with new products and technology enhancements.
Challenges include navigating potential market dynamics changes due to ACA subsidy adjustments, but Oscar Health is proactively addressing these concerns.

Oscar Health posts record revenue and profitability, eyes market expansion

Oscar Health delivered robust Q1 results, showcasing strong revenue growth, improved profitability, and strategic market expansion initiatives.
Despite facing challenges in achieving total company adjusted EBITDA profitability, the company's financial stability and growth prospects remain promising.
With a focus on operational efficiency and long-term strategic vision, Oscar Health is well-positioned to capitalize on market opportunities and drive sustained growth.

Oscar Health reports strong Q2 results, eyes growth through technology

Oscar Health's Q2 2024 earnings call showcased robust financial performance, driven by revenue growth and improved EBITDA. The company's membership expansion and strategic focus on technology-driven engagement are key strengths. Challenges include policy uncertainties and meeting raised guidance, while opportunities exist in market resonance and technological advancements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Harvard Business School classmates Josh Kushner, Mario Schlosser, and Kevin Nazemi decide to start a company to demystify health insurance.

Oscar, named after Kushner's great grandfather, raises $51.5 million through Series A, AA, and AAA funding from Gary Vaynerchuk, Dave Gilboa, Khosla Ventures, Lerer Ventures, General Catalyst Thrive Capital, Founders Fund, Kal Vepuri, BoxGroup and more, with a pre-money valuation of $70 million.

Series A4 funding drops a nice $30 million from investors into Oscar's wallet, bumping its valuation to $310 million.

Oscar secures $80 million in Series A5 funding, mostly from Formation 8. Pre-money valuation reaches $500 million.

Nearly 150,000 members call themselves Oscar-insured across four states alone (NY, NJ, CA, & TX).

Oscar's member services team sets up camp in Tempe, Ariz.

Mount Sinai Health System partners to open the Oscar Center, offering primary care, mental health, and wellness services to members—sort of like a fancy urgent care. 😎

Oscar offers coverage to New York small businesses for their employees. 

The Cleveland Clinic collab drops in the Midwest market to cover individuals across northeastern Ohio. 

Oscar expands to new regions, including Tennessee, Ohio, Texas, New Jersey, and California.

Hey, y’all: A partnership with Humana helps Oscar cover small businesses up to 50 employees in Nashville, Tenn.

Series G round nets Oscar $165 million in funding, zooming the estimated value to a whopping $3.2 billion.

Alphabet (parent company to Google) decides to invest, cutting Oscar a check for $375 million.

The "Cigna + Oscar" collab brings together Cigna's vast network to Oscar's member-focused experience for small businesses. 

Gary Vaynerchuk and Khosla Ventures go for round 2, but this time, a sweet $225 million with the help of Builders VC.

Tiger Global Management invests $140 million in Oscar, as the company's member count exceeds 400,000.

Oscar begins trading on the New York Stock Exchange under the ticker $OSCR.

Investors liked the health insurer's latest quarterly update.

Why Oscar Health Stock Is Skyrocketing Today

Oscar Health, Inc. (NYSE:OSCR ) Q4 2022 Earnings Conference Call February 9, 2023 5:00 PM ET Company Participants Cornelia Miller – Vice President of Corporate Development and Investor Relations Mario Schlosser – Co-Founder and Chief Executive Officer Sid Sankaran – Chief Financial Officer Conference Call Participants Michael Ha – Morgan Stanley Jonathan Yong – Credit Suisse Gary Taylor – Cowen Kevin Fischbeck – Bank of America Josh Raskin – Nephron Research Nathan Rich – Goldman Sachs Stephen Baxter – Wells Fargo Operator Good afternoon. My name is Regina and I will be your conference operator today.

Oscar Health, Inc. (OSCR) Q4 2022 Earnings Call Transcript

The digital healthcare arena continues transforming healthcare delivery while broadening access for patients. This, as health technology company and insurance platform Oscar Health told investors on Thursday's (Feb. 9) fourth quarter 2022 earnings call that its membership numbers for the year rose to a record total of 1,151,483.

Oscar Health Nearly Doubled Its Member Base in 2022

Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of -3.96% and 10.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Oscar Health, Inc. (OSCR) Reports Q4 Loss, Tops Revenue Estimates

NEW YORK--(BUSINESS WIRE)--Health tech company Oscar Health, Inc. (NYSE: OSCR) today announced its financial results for the fourth quarter and year ended December 31, 2022 including significant improvement in core operating margins, delivering ~5 points of Combined Ratio improvement YoY.

Oscar Health Announces Results for Fourth Quarter and Full Year 2022

Oscar Health, Inc. has developed a product that may address the inefficiencies of the U.S. healthcare system. Oscar Health has multiple channels and strategies that it can tap on to expand its total addressable market.

Oscar Health: Wait For Concrete Evidence The Business Can Turn Profitable

NEW YORK--( BUSINESS WIRE )--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, will release its fourth quarter 2022 and full year 2022 financial results after market close on Thursday, February 9, 2023.

Oscar Health, Inc. 2022 Fourth Quarter and Full Year Earnings Conference Call

NEW YORK--( BUSINESS WIRE )--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today announced that Co-Founder & CEO, Mario Schlosser, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 5:15 PM PT (8:15 PM ET) in San Francisco, CA.

Oscar Health, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference

NEW YORK--( BUSINESS WIRE )--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, announced that based on strong Open Enrollment performance to date, it will temporarily stop accepting new members in the state of Florida, beginning December 13 at 12:00 a.m. EST. Individuals seeking Oscar coverage in Florida can continue to enroll without limitation until that time.

Oscar Health, Inc. to Limit Additional Growth in Florida in Light of Strong Open Enrollment

NEW YORK--( BUSINESS WIRE )--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first healthcare company built on a full stack technology platform, today announced the results of a comprehensive survey on consumer attitudes toward healthcare. The survey highlights the importance of health security at a time of economic uncertainty, as well as the changing consumer sentiment towards healthcare and health insurance, as the country emerges from the effects of the COVID pandemic.

Oscar Health Survey Details Connection Between Economic and Health Security, With More Individuals Reassessing Their Health Insurance and Prioritizing Their Healthcare Needs

NEW YORK--( BUSINESS WIRE )--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today announced that Bill Gassen and Laura Lang have been appointed to its Board of Directors. They have joined the board in an official capacity effective today, December 7, 2022. Ms. Lang was also appointed as Chair of the Compensation Committee of the Board and Mr. Gassen was also appointed as a member of the Nominating and Corporate Governance Committee of the Board.

Oscar Health Appoints Bill Gassen and Laura Lang To Its Board of Directors

NASHVILLE, Tenn. & NEW YORK--( BUSINESS WIRE )--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today announced that Vanderbilt University Medical Center (VUMC) is an in-network provider in the Nashville, TN area. VUMC joins Oscar's existing Southeast network as individuals are actively shopping for health insurance during this year's Open Enrollment period. This network addition will help expand access for more individuals across the Nashville area and will bring VUMC providers and facilities in-network for Oscar's individual and family health insurance plans beginning January 1, 2023.

Oscar Health Announces Expansion with Vanderbilt University Medical Center To Provide In-Network Health Coverage for Residents Across the Nashville Region

NEW YORK--( BUSINESS WIRE )--Thrive Capital confirmed today that there have been no changes to its ownership of Oscar Health, Inc. (the "Company") (NYSE: OSCR). Its ownership remains as was disclosed in its Schedule 13D filed with the Securities and Exchange Commission on February 4, 2022 (https://www.sec.gov/Archives/edgar/data/1568651/000119312522028503/d288826dsc13da.htm).

Thrive Capital 13F Update, Oscar Health

Oscar Health has fallen over 67% YTD as a result of the microeconomic environment and loss of a large customer. However, its growth has sustained, and its key ratios have continued to sustain.

Oscar Health Is Back On Track

Oscar Health, Inc. (NYSE:OSCR ) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Cornelia Miller - Vice President, Corporate Development and Investor Relations Mario Schlosser - Co-Founder and Chief Executive Officer Scott Blackley - Chief Financial Officer Sid Sankaran - Interim Chief Financial Officer Conference Call Participants Connor Massari - Morgan Stanley Stephen Baxter - Wells Fargo Nathan Rich - Goldman Sachs Josh Raskin - Nephron Research Operator Good afternoon. My name is Josh and I will be your conference operator today.

Oscar Health, Inc. (OSCR) Q3 2022 Earnings Call Transcript

NEW YORK--(BUSINESS WIRE)--Health insurtech company Oscar Health, Inc. (NYSE: OSCR) today announced its financial results for the third quarter ended September 30, 2022.

Oscar Health Announces Results for Third Quarter 2022

Oscar Announces HCA Midwest Health as In-Network Provider For its Affordable Care Act Plans Across the Kansas City Area

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, will release its third quarter 2022 financial results after market close on Tuesday, November 8, 2022.

Oscar Health, Inc. 2022 Third Quarter Conference Call

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today announced this year's grantees for its Culturally Competent Care Grant Program. This is the second year of the program, with Oscar awarding $150,000 to organizations across the U.S. that are working to increase care access for underserved communities. Oscar defines culturally competent care as providing care to patients with diverse values, be

Oscar Health, Inc. Announces New Class of Culturally Competent Care Grantees to Help Underserved Communities

Oscar Health's stock price has seen a precipitous decline, yet the company's financial performance continues to be strong on key metrics. Oscar Health has demographic and technological tailwinds that can drive the growth in users and optimize efficiencies for the business.

Oscar Health: Improving Risk/Reward Profile To Watch

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today announced Co-Founder & CEO, Mario Schlosser, and CFO, Scott Blackley, are scheduled to present and provide a business update at the 2022 Wells Fargo Healthcare Conference on Thursday, September 8, 2022. Senior management is also scheduled to present and provide a business update at the 20th Annual Morgan Stanley Global Healthcare Conferenc

Oscar Health, Inc. Announces Participation at Upcoming Conferences

Cigna

PHILADELPHIA & NEW YORK--(BUSINESS WIRE)--Cigna Corporation (NYSE: CI), a leading global health service company, and Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, announced that Cigna + Oscar2 small business health insurance will be available across the Philadelphia metro area, including Bucks, Chester, Delaware, Montgomery, and Philadelphia counties beginning January 1, 2023, pending regulatory approval. “A healthy work

Cigna + Oscar Expands Footprint to Bring Small Businesses in Philadelphia Access to Cost-Effective Health Plans

Oscar Health, Inc. (NYSE:OSCR ) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Cornelia Miller - Vice President of Corporate Development & Investor Relations Mario Schlosser - Co-Founder & Chief Executive Officer Scott Blackley - Chief Financial Officer Conference Call Participants Michael Hall - Morgan Stanley Stephen Baxter - Wells Fargo Securities Jonathan Yong - Credit Suisse Kevin Fischbeck - Bank of America Josh Raskin - Nephron Research Lindsay Golub - Goldman Sachs Operator Good afternoon. My name is Christian and I will be your conference operator today.

Oscar Health, Inc. (OSCR) CEO Mario Schlosser on Q2 2022 Results - Earnings Call Transcript

NEW YORK--(BUSINESS WIRE)--Health insurtech company Oscar Health, Inc. (NYSE: OSCR) today announced its financial results for the second quarter ended June 30, 2022. “Oscar's first half results reflect our continued momentum and demonstrate our technology platform's differentiated ability to support our increasing scale.” said Mario Schlosser, CEO and Co-Founder of Oscar. “We remain laser-focused on the execution of our strategic plan to reach our profitability target for the Insurance product

Oscar Health Announces Results for Second Quarter 2022

NEW YORK , July 11, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR) and certain of its officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 22-cv-04103, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Oscar Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's March 2021 initial public offering ("IPO" or the "Offering").

SHAREHOLDER ALERT FILING DEADLINE TODAY: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Oscar Health, Inc. of Class Action Lawsuit and Upcoming Deadline - OSCR

News for Oscar Health Stock (OSCR)